ITM is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment. We are developing a proprietary portfolio and growing pipeline of targeted treatments in various stages of clinical development addressing cancers such as neuroendocrine cancers or bone metastases. Our main objectives are to significantly improve treatment outcomes and quality of life for cancer patients through a new generation of Targeted Radionuclide Therapies in Precision Oncology. The headquarters are located in the heart of the research center of the Technical University of Munich (TUM).
We would like to fill the following vacancy as soon as possible: Early Clinical Development Lead (f/m/d).
ITM Oncologics is growing rapidly. This is an ideal opportunity for an ambitious clinical development physician to be a part of this evolving company. This is a key role within the medical group reporting to the Head of Clinical Development. The successful candidate will be expected to develop his/her team to lead the transition of early products from preclinical to their clinical development in Phase I/II.